Company Announcements
Director/PDMR Shareholding
Related Companies
By LSE RNS
26 October 2017
Cello Group plc
("Cello" or the "Company")
Director/PDMR Shareholding
The Company has been notified that, on 26 October 2017, Alistair Shirley, a person closely associated with Jane Shirley, CEO of Cello Health Europe and Cello Health Insight, purchased 2,000 ordinary shares of 10 pence each in the capital of the Company, at a price of approximately 133 pence per share.
Following the above transaction, Jane Shirley and her persons closely associated hold 80,000 ordinary shares, representing approximately 0.1% of the Company's issued ordinary share capital.
Enquiries:
|
Cello Group |
020 7812 8460 |
|
Mark Scott, Chief Executive |
|
|
Mark Bentley, Finance Director |
|
|
|
|
|
Cenkos Securities |
0207 397 8900 |
|
Bobbie Hilliam Harry Hargreaves |
|
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a) |
Name |
Alistair Shirley |
||||
|
2 |
Reason for the notification |
|||||
|
a) |
Position/status |
Person closely associated with Jane Shirley |
||||
|
b) |
Initial notification /Amendment |
Initial notification |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a) |
Name |
Cello Group plc |
||||
|
b) |
LEI |
2138004TZYGZLWQP7N64 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a)
|
Description of the financial instrument, type of instrument
Identification code |
Ordinary Shares of 10p each
GB00B0310763 |
||||
|
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
||||
|
c)
|
Price(s) and volume(s)
|
|
||||
|
d) |
Aggregated information
-Aggregated volume
-Price |
2,000
£2,660.00 |
||||
|
e) |
Date of the transaction |
26 October 2017 |
||||
|
f) |
Place of the transaction |
XLON |
||||
This information is provided by RNS
You are here: news > regulatory news
10 Lower Thames St,
London EC3R 6EN